Praxis Precision Medicines (PRAX) Assets Average (2020 - 2026)

Praxis Precision Medicines' Assets Average history runs 7 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• In Q1 2026, Assets Average rose 149.32% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (up 149.32% YoY), while the FY2025 annual figure was $710.5 million, up 148.84% from the prior year.
• Assets Average for Q1 2026 stood at $1.2 billion, up from $667.1 million in the prior quarter.
• The five-year high for Assets Average was $1.2 billion in Q1 2026, with the low at $97.3 million in Q4 2023.
• The 5-year median for Assets Average is $266.1 million (2022), against an average of $343.0 million.
• The sharpest annual moves came in 2023 and 2024: Assets Average slumped 59.89% in 2023, then soared 361.99% in 2024.
• Praxis Precision Medicines' Assets Average stood at $126.0 million in 2022, then retreated by 22.76% to $97.3 million in 2023, then jumped by 361.99% to $449.7 million in 2024, then surged by 48.36% to $667.1 million in 2025, then soared by 79.73% to $1.2 billion in 2026.
• Business Quant data shows PRAX's Assets Average at $1.2 billion in Q1 2026, $667.1 million in Q4 2025, and $424.6 million in Q3 2025.